AbCellera Biologics ABCL
NASDAQ ABCL
$12.02 +0.31 (+2.69%)
As of: Oct 21, 2026 · 11:41 AM EDT

AbCellera Biologics (ABCL) Other financing activities (2020)

Updated

AbCellera Biologics' Other financing activities was $799,000 in Q1 2020.

Analysis

AbCellera Biologics (ABCL) Other financing activities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 AbCellera Biologics 3.70 Bn 3.16 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -799,000.00
API Access

AbCellera Biologics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ABCL&period=max&api_key=YOUR_API_KEY